Showing results (91-100 of 188) with videos related to

Sort By:
Pageof 19
Annals of Surgical Oncology|June 1, 1997
Sensitizing T-lymphocytes for adoptive immunotherapy by vaccination with wild-type or cytokine gene-transduced melanomaK A Lipshy, P J Kostuchenko, G G Hamad, et al.
Scientific Reports|June 30, 2022
Neighborhood disadvantage and biological aging biomarkers among breast cancer patientsJie Shen, Bernard F Fuemmeler, Vanessa B Sheppard, et al.
Surgery|March 16, 2013
Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burdenOmar M Rashid, Masayuki Nagahashi, Subramaniam Ramachandran, et al.
Cancer Research|February 1, 1992
Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1T M Tuttle, T H Inge, K P Bethke, et al.
Leukemia|July 1, 1996
Effect of AS101 on bryostatin 1-mediated differentiation induction, cell cycle arrest, and modulation of drug-induced apoptosis in human myeloid leukemia cellsA S Rao, A J Freemerman, W D Jarvis, et al.
Cancer Gene Therapy|September 20, 2014
Expansion of melanoma-specific lymphocytes in alternate gamma chain cytokines: gene expression variances between T cells and T-cell subsets exposed to IL-2 versus IL-7/15C K Zoon, E Seitelman, S Keller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase Ib trial of bryostatin 1 in patients with refractory malignanciesS Grant, J Roberts, E Poplin, et al.
Plos One|July 16, 2015
Perceived Stress Levels, Chemotherapy, Radiation Treatment and Tumor Characteristics Are Associated with a Persistent Increased Frequency of Somatic Chromosomal Instability in Women Diagnosed with Breast Cancer: A One Year Longitudinal StudyNoran Aboalela, Debra Lyon, R K Elswick, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1991
A cytotoxic T-lymphocyte clone derived from mice with progressively growing tumorsS K Hoover, T H Inge, J L Frank, et al.
The Journal of Surgical Research|June 1, 1992
Bryostatin 1-activated T cells can traffic and mediate tumor regressionT M Tuttle, K P Bethke, T H Inge, et al.
Pageof 19